- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Study Shows Collaboration Benefits with Pharma and Non-Profits
Accenture, a global professional services company, released findings from its new Patient Services Study. The study shows that more collaboration between pharma companies and nonprofit organizations that support services and advocate for patients would deliver better patient experiences.
The study, which surveyed 4,000 U.S. and European patients, examines the role that patient organizations play in providing support, information, and other services to patients and whether better collaboration with pharma companies could improve the patient experience and care. The study focused on three different diseases/medical conditions-migraine, rheumatoid arthritis, and chronic lymphocytic leukemia-selected due to their significant, yet different, impact on patients’ daily lives.
To read the full study, visit here.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
